{"id":"https://openalex.org/W27112539","doi":"https://doi.org/10.1182/blood.v90.8.3179","title":"Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24","display_name":"Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24","publication_year":1997,"publication_date":"1997-10-15","ids":{"openalex":"https://openalex.org/W27112539","doi":"https://doi.org/10.1182/blood.v90.8.3179","mag":"27112539","pmid":"https://pubmed.ncbi.nlm.nih.gov/9376601"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v90.8.3179","doi":"https://doi.org/10.1182/blood.v90.8.3179","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v90.8.3179","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1182/blood.v90.8.3179","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001924375","display_name":"Shuji Ozaki","orcid":"https://orcid.org/0000-0002-9808-0752","observed_orcids":["https://orcid.org/0000-0002-9808-0752"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shuji Ozaki","raw_affiliation_strings":["From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I922474255"]},{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065648065","display_name":"Masaaki Kosaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaaki Kosaka","raw_affiliation_strings":["From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I922474255"]},{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113668005","display_name":"Shingo Wakatsuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shingo Wakatsuki","raw_affiliation_strings":["From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I922474255"]},{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088707445","display_name":"Masahiro Abe","orcid":"https://orcid.org/0000-0002-9317-7133","observed_orcids":["https://orcid.org/0000-0002-9317-7133"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Abe","raw_affiliation_strings":["From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I922474255"]},{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031781312","display_name":"Yasuo Koishihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuo Koishihara","raw_affiliation_strings":["From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I922474255"]},{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004644505","display_name":"Toshio Matsumoto","orcid":"https://orcid.org/0000-0002-0618-0941","observed_orcids":["https://orcid.org/0000-0002-0618-0941"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Matsumoto","raw_affiliation_strings":["From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima; and Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co, Ltd, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473","https://openalex.org/I922474255"]},{"raw_affiliation_string":"From the First Department of Internal Medicine, School of Medicine, University of Tokushima, Tokushima","institution_ids":["https://openalex.org/I922474255"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":{"value":5500,"currency":"USD","value_usd":5500},"fwci":2.4794,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.88205164,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"90","issue":"8","first_page":"3179","last_page":"3186"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9610000252723694},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/scid-mice","display_name":"SCID mice","score":0.9390000104904175},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5809999704360962},{"id":"https://openalex.org/keywords/plasma-cell-dyscrasia","display_name":"plasma cell dyscrasia","score":0.8299999833106995},{"id":"https://openalex.org/keywords/rpmi-8226-cells","display_name":"RPMI 8226 cells","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C2779468541","wikidata":"https://www.wikidata.org/wiki/Q1334408","display_name":"Severe combined immunodeficiency","level":3,"score":0.6658902168273926},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6169256567955017},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5887295603752136},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.568739116191864},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5604680776596069},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5561514496803284},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5308257937431335},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.5266116857528687},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5029594302177429},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4903602600097656},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4173106849193573},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41435328125953674},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3052052855491638},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3015422224998474},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2598450779914856},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.20697855949401855},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074010","descriptor_name":"Bone Marrow Stromal Antigen 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v90.8.3179","doi":"https://doi.org/10.1182/blood.v90.8.3179","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v90.8.3179","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:9376601","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9376601","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/blood.v90.8.3179","doi":"https://doi.org/10.1182/blood.v90.8.3179","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v90.8.3179","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W74017565","https://openalex.org/W281972821","https://openalex.org/W283720115","https://openalex.org/W342350979","https://openalex.org/W1501804942","https://openalex.org/W1516195543","https://openalex.org/W1530277278","https://openalex.org/W1553576196","https://openalex.org/W1557074909","https://openalex.org/W1557553149","https://openalex.org/W1587500817","https://openalex.org/W1591742657","https://openalex.org/W1599670023","https://openalex.org/W1914208484","https://openalex.org/W1964857102","https://openalex.org/W2009293121","https://openalex.org/W2022758023","https://openalex.org/W2023674080","https://openalex.org/W2065459588","https://openalex.org/W2068441417","https://openalex.org/W2097593324","https://openalex.org/W2129224302","https://openalex.org/W2137474508","https://openalex.org/W2151195343","https://openalex.org/W2152894118","https://openalex.org/W2154789907","https://openalex.org/W2169508891","https://openalex.org/W2289177026","https://openalex.org/W2293117933","https://openalex.org/W2333877843","https://openalex.org/W2340762582","https://openalex.org/W2404088503","https://openalex.org/W2412808367","https://openalex.org/W2417212547","https://openalex.org/W2441490494","https://openalex.org/W2513571839","https://openalex.org/W3113313371","https://openalex.org/W6610249498","https://openalex.org/W6633254295","https://openalex.org/W6633343290"],"related_works":["https://openalex.org/W7145201608","https://openalex.org/W2282610461","https://openalex.org/W1979711385","https://openalex.org/W2086063536","https://openalex.org/W2011061970","https://openalex.org/W1516195543","https://openalex.org/W2140698733","https://openalex.org/W2146939792","https://openalex.org/W2553606204","https://openalex.org/W2581486206"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1,61,90,118,152,196],"remains":[2],"an":[3],"incurable":[4],"malignancy":[5],"because":[6],"of":[7,10,55,72,88,106,116,129,149,194],"marked":[8],"resistance":[9],"tumor":[11,112,134,141],"cells":[12,153,171],"to":[13,21],"conventional":[14],"chemotherapeutic":[15],"agents.":[16],"Alternative":[17],"strategies":[18],"are":[19],"needed":[20],"solve":[22],"these":[23],"problems.":[24],"To":[25],"develop":[26],"a":[27,33,39,102,144],"new":[28],"strategy,":[29],"we":[30,48],"have":[31],"generated":[32],"monoclonal":[34],"antibody":[35,167],"(MoAb),":[36],"which":[37],"detects":[38],"human":[40,60,89,151],"plasma":[41,199],"cell-specific":[42],"antigen,":[43],"HM1.24.":[44],"In":[45,122],"this":[46],"report,":[47],"evaluated":[49],"the":[50,114,133,166],"in":[51,79,143,156],"vivo":[52],"antitumor":[53],"effect":[54],"unconjugated":[56],"anti-HM1.24":[57,107,130,159,187],"MoAb":[58,108,131,188],"on":[59],"xenografts":[62],"implanted":[63],"into":[64],"severe":[65],"combined":[66],"immunodeficiency":[67],"(SCID)":[68],"mice.":[69],"Two":[70],"models":[71],"disseminated":[73,117],"or":[74,85],"localized":[75],"tumors":[76],"were":[77,99],"established":[78],"SCID":[80,173],"mice":[81,98,123,174],"by":[82,158,165],"either":[83],"intravenous":[84],"subcutaneous":[86],"injection":[87,105],"cell":[91,177,200],"lines,":[92],"ARH-77":[93],"and":[94,136,197],"RPMI":[95,180],"8226.":[96],"When":[97],"treated":[100],"with":[101],"single":[103],"intraperitoneal":[104],"1":[109],"day":[110],"after":[111],"inoculation,":[113],"development":[115],"was":[119,154],"completely":[120],"inhibited.":[121],"bearing":[124],"advanced":[125],"tumors,":[126],"multiple":[127,195],"injections":[128],"reduced":[132],"size":[135],"significantly":[137],"prolonged":[138],"survival,":[139],"including":[140],"cure,":[142],"dose-dependent":[145],"manner.":[146],"The":[147],"proliferation":[148],"cultured":[150],"inhibited":[155],"vitro":[157],"IgG-mediated":[160],"complement-dependent":[161],"cytotoxicity,":[162],"but":[163],"not":[164],"alone.":[168],"Moreover,":[169],"spleen":[170],"from":[172],"mediated":[175],"antibody-dependent":[176],"cytotoxicity":[178],"against":[179],"8226":[181],"cells.":[182],"These":[183],"results":[184],"indicate":[185],"that":[186],"can":[189],"be":[190],"used":[191],"for":[192],"immunotherapy":[193],"related":[198],"dyscrasias.":[201]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}